Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder.

Literature DB >> 8657838

A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder.

D G Baker¹, B I Diamond, G Gillette, M Hamner, D Katzelnick, T Keller, T A Mellman, E Pontius, M Rosenthal, P Tucker.

Abstract

A large multi-center, double-blind, parallel trial to assess the efficacy of brofaromine in the treatment of post traumatic stress disorder (PTSD) failed to show a significant difference between the brofaromine and placebo treatment groups. The placebo response rate in this study was higher than that in previously published double-blind, placebo-controlled studies of PTSD.

Entities: Chemical Disease

Mesh：

Substances：

Year: 1995 PMID： 8657838 DOI： 10.1007/bf02246271

Source DB: PubMed Journal: Psychopharmacology (Berl) ISSN： 0033-3158 Impact factor: 4.530

14 in total

1. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine.

Authors: T R Kosten; J B Frank; E Dan; C J McDougle; E L Giller
Journal: J Nerv Ment Dis Date: 1991-06 Impact factor: 2.254

2. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder.

Authors: J B Frank; T R Kosten; E L Giller; E Dan
Journal: Am J Psychiatry Date: 1988-10 Impact factor: 18.112

3. A controlled trial of phenelzine in posttraumatic stress disorder.

Authors: M Shestatzky; D Greenberg; B Lerer
Journal: Psychiatry Res Date: 1988-05 Impact factor: 3.222

4. Treatment of posttraumatic stress disorder with amitriptyline and placebo.

Authors: J Davidson; H Kudler; R Smith; S L Mahorney; S Lipper; E Hammett; W B Saunders; J O Cavenar
Journal: Arch Gen Psychiatry Date: 1990-03

5. Post-traumatic stress disorder in the general population. Findings of the epidemiologic catchment area survey.

Authors: J E Helzer; L N Robins; L McEvoy
Journal: N Engl J Med Date: 1987-12-24 Impact factor: 91.245

6. A new depression scale designed to be sensitive to change.

Authors: S A Montgomery; M Asberg
Journal: Br J Psychiatry Date: 1979-04 Impact factor: 9.319

Review 7. Brofaromine--a selective, reversible, and short-acting MAO-A inhibitor: review of the pharmacological and clinical findings.

Authors: H J Möller; G Wendt; P Waldmeier
Journal: Pharmacopsychiatry Date: 1991-03 Impact factor: 5.788

8. Impact of Event Scale: a measure of subjective stress.

Authors: M Horowitz; N Wilner; W Alvarez
Journal: Psychosom Med Date: 1979-05 Impact factor: 4.312

9. A controlled trial of desipramine in 18 men with posttraumatic stress disorder.

Authors: C Reist; C D Kauffmann; R J Haier; C Sangdahl; E M DeMet; A Chicz-DeMet; J N Nelson
Journal: Am J Psychiatry Date: 1989-04 Impact factor: 18.112

16 in total

Review 1. Post-traumatic stress disorder: a review of recent findings.

Authors: S Seedat; M B Stein
Journal: Curr Psychiatry Rep Date: 2001-08 Impact factor: 5.285

Review 2. New directions in the pharmacotherapy of posttraumatic stress disorder.

Authors: Charles R Marmar; Thomas C Neylan; Frank B Schoenfeld
Journal: Psychiatr Q Date: 2002

3. Posttraumatic Stress Disorder and Acute Stress Disorder II: Considerations for Treatment and Prevention.

Authors: Shawn P Cahill; Kristin Pontoski; Carla M D'Olio
Journal: Psychiatry (Edgmont) Date: 2005-09

4. Screening antidepressants in the chick separation-stress paradigm.

Authors: Matthew W Feltenstein; Kenneth J Sufka
Journal: Psychopharmacology (Berl) Date: 2005-10-15 Impact factor: 4.530

Review 5. Post-traumatic stress disorder in women: epidemiological and treatment issues.

Authors: Soraya Seedat; Dan J Stein; Paul D Carey
Journal: CNS Drugs Date: 2005 Impact factor: 5.749

Review 6. Post-traumatic stress disorder: emerging concepts of pharmacotherapy.

Authors: Dewleen G Baker; Caroline M Nievergelt; Victoria B Risbrough
Journal: Expert Opin Emerg Drugs Date: 2009-06 Impact factor: 4.191

Review 7. Pharmacotherapy in post-traumatic stress disorder: evidence from randomized controlled trials.

Authors: Gregory M Sullivan; Yuval Neria
Journal: Curr Opin Investig Drugs Date: 2009-01

Review 8. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.

Authors: Gregory M Asnis; Shari R Kohn; Margaret Henderson; Nicole L Brown
Journal: Drugs Date: 2004 Impact factor: 9.546

9. Pharmacotherapy of PTSD: Current Status and Controversies.

Authors: Gregory M Sullivan; Yuval Neria
Journal: Psychiatr Ann Date: 2009-06

10. Psychopharmacotherapy of posttraumatic stress disorder.

Authors: Dragica Kozaric-Kovacic
Journal: Croat Med J Date: 2008-08 Impact factor: 1.351